« ALEA Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Trump Has �Financial Interest� in Hydroxychloroquine Manufacturer: NYT

By: xcslewis in ALEA | Recommend this post (0)
Tue, 07 Apr 20 4:04 PM | 22 view(s)
Boardmark this board | The Trust Matrix
Msg. 35322 of 54959
(This msg. is a reply to 35319 by clo)

Jump:
Jump to board:
Jump to msg. #

Margot Cleveland@ProfMJCleveland

Evolution of media's anti-Trump hydroxychloroquine spin would leave even Darwin dizzy:
1) Trump giving Americans false hope.
2) Trump peddling snake oil.
3) Trump made couple drink fish tank cleaner.
4) Hydroxychloroquine might, maybe, be helpful.
5) Trump is in it for money.

@Cernovich
According to Trump’s financial disclosure, he owns between $1,000 - $15,000 of Dodge & Cox fund.

Dox & Cox’s fund has 2.9% of its money in Sanofi.
Trump owns 2.9% of btw $1,000 - $15,000.
Trump owns $29 to $435 of stock.

sigh.




» You can also:
- - - - -
The above is a reply to the following message:
Trump Has ‘Financial Interest’ in Hydroxychloroquine Manufacturer: NYT
By: clo
in ALEA
Tue, 07 Apr 20 2:21 PM
Msg. 35319 of 54959

Trump Has ‘Financial Interest’ in Hydroxychloroquine Manufacturer: NYT
THERE IT IS

Justin Baragona Contributing Editor
Updated Apr. 07, 2020 4:10

President Donald Trump has a “small financial interest” in the maker of an anti-malarial drug that he has been touting as a “game changer” in treating coronavirus, according to The New York Times. Over the past two weeks, Trump and his Fox News allies have aggressively promoted hydroxychloroquine as a potential cure, despite top infectious-disease expert Dr. Anthony Fauci and others urging caution and noting that there was not enough evidence of the drug’s efficacy.

The Times reports the president’s family trusts all have investments in a mutual fund whose largest holding is Sanofi, the manufacturer of Plaquenil, the brand-name version of hydroxychloroquine. Associates of the president, including Commerce Secretary Wilbur Ross, have also run funds that hold investments in the pharmaceutical firm.

Read it at The New York Times


« ALEA Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next